Novo-Nordisk, DK0062498333

Novo-Nordisk stock falls 3.12 percent ahead of the open

Published on 09/25/2026 at 06:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 24, 2026, Novo-Nordisk stock stood at USD 38.17 after falling 3.12 percent. The S&P 500 slipped 0.02 percent to 7,704.13 as strategic targets drew scrutiny.

Modernes nordisches Forschungszentrum, Glasfassade, Skandinavisches Architekturdesign
Novo Nordisk A/S (DK0062498333): nordisches Forschungszentrum mit Glasfassade und klaren skandinavischen Linien, Illustration mit AI erstellt.

Novo-Nordisk stock closed at USD 38.17 on Nasdaq on September 24, 2026, down 3.12 percent from the prior session. The shares underperformed the S&P 500, which fell 0.02 percent to 7,704.13 on the same session date.

September 24, 2026 in numbers

Novo Nordisk A/S (ISIN DK0062498333) traded in the context of a strategic update presented on September 21, 2026. As GuruFocus reported, the company announced plans for at least five new blockbuster drugs by 2030, while analysts criticized the update as lacking substantial new information.

The Nasdaq-listed American depositary shares closed at USD 38.17 on September 24, 2026, compared with USD 39.40 at the close of the prior Tuesday cited by The Globe and Mail.

September 25, 2026 events

US economic releases due today include durable goods orders at 7:30 a.m. ET and the University of Michigan consumer sentiment report at 10:00 a.m. ET, according to Investing.com. The releases can affect rate-sensitive healthcare valuations through their effect on interest-rate expectations.

Disclaimer...

en | DK0062498333 | NOVO-NORDISK | boerse | 70181330 | bgmi